Suppr超能文献

缓激肽可拮抗α-凝血酶的作用。

Bradykinin antagonizes the effects of alpha-thrombin.

作者信息

Ehringer W D, Edwards M J, Gray R D, Miller F N

机构信息

Center for Applied Microcirculatory Research, University of Louisville School of Medicine, Kentucky 40292, USA.

出版信息

Inflammation. 1997 Jun;21(3):279-98. doi: 10.1023/a:1027345832138.

Abstract

alpha-Thrombin (AT) and bradykinin (BK) are endogenous mediators that are released during an inflammatory response, and could have a synergistic effect on endothelial permeability. Human umbilical vein endothelial cells (HUVEC) were grown on Transwell membranes and then tested for alterations in permeability to fluorescein isothiocyanate-labeled human serum albumin. Addition of 1 microM AT produced a significant increase in the permeability coefficient at 30 minutes from control levels of 1.59 x 10(-6) cm/sec to 4.92 x 10(-6) cm/sec. BK (1 microM) produced a similar increase to 4.46 x 10(-6) cm/sec. For both compounds, permeability remained elevated for 90 minutes. Pre-treatment of the HUVEC with the bradykinin receptor antagonist, Na-adamantaneacetyl-bradykinin (NA-BK) (1 microM), prior to addition of AT, reduced the AT permeability coefficient to 2.69 x 10(-6) cm/sec. Addition of NA-BK (1 microM) for 5 minutes, then BK (1 microM) for 5 minutes, inhibited the effect of BK and of AT (1 microM on permeability, decreasing the permeability coefficient of the endothelial monolayer to control levels (1.62 x 10(-6) cm/sec). AT (1 microM) increased HUVEC intracellular calcium mobilization, as monitored by FURA-2, to 245 nM from control (70 nM), however, pre-treatment with either BK or the bradykinin receptor antagonist decreased the AT induced intracellular calcium mobilization compared to AT alone. Pre-treatment of the HUVEC with bradykinin (1 microM) for 2 minutes also inhibited the effects of alpha-thrombin (1 microM) on f-actin distribution examined by BODIPY-phallodin staining and increased the clotting times for an alpha-thrombin dependent fibrinogen to fibrin clotting assay. However, incubation of bradykinin (1 microM) with alpha-thrombin (1 microM) for either 10 minutes or 100 minutes produced no detectable hydrolysis products. These data strongly suggest that the inflammatory mediators alpha-thrombin and bradykinin when released together, rather than being synergistic, are antagonistic.

摘要

α-凝血酶(AT)和缓激肽(BK)是在炎症反应过程中释放的内源性介质,它们可能对内皮通透性产生协同作用。人脐静脉内皮细胞(HUVEC)生长在Transwell膜上,然后检测其对异硫氰酸荧光素标记的人血清白蛋白通透性的变化。添加1微摩尔/升的AT可使30分钟时的通透系数从对照水平的1.59×10⁻⁶厘米/秒显著增加至4.92×10⁻⁶厘米/秒。BK(1微摩尔/升)产生类似的增加,达到4.46×10⁻⁶厘米/秒。对于这两种化合物,通透性在90分钟内一直保持升高。在添加AT之前,用缓激肽受体拮抗剂金刚烷乙酰缓激肽钠(NA-BK)(1微摩尔/升)对HUVEC进行预处理,可将AT的通透系数降低至2.69×10⁻⁶厘米/秒。添加NA-BK(1微摩尔/升)5分钟,然后添加BK(1微摩尔/升)5分钟,可抑制BK和AT(1微摩尔/升)对通透性的影响,使内皮单层的通透系数降至对照水平(1.62×10⁻⁶厘米/秒)。如用FURA-2监测,1微摩尔/升的AT可使HUVEC细胞内钙动员从对照水平的70纳摩尔增加至245纳摩尔,然而,与单独使用AT相比,用BK或缓激肽受体拮抗剂进行预处理可降低AT诱导的细胞内钙动员。用缓激肽(1微摩尔/升)对HUVEC进行2分钟预处理,也可抑制α-凝血酶(1微摩尔/升)对通过BODIPY-鬼笔环肽染色检测的f-肌动蛋白分布的影响,并增加α-凝血酶依赖性纤维蛋白原至纤维蛋白凝血测定的凝血时间。然而,将缓激肽(1微摩尔/升)与α-凝血酶(1微摩尔/升)一起孵育10分钟或100分钟未产生可检测到的水解产物。这些数据强烈表明,炎症介质α-凝血酶和缓激肽一起释放时,不是协同作用,而是拮抗作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验